期刊文献+

不同冠脉病变支数的急性冠脉综合征患者血浆MMP-9水平研究

Study of the plasma MMP-9 level of the different number of coronary lesions in patients with acute coronary syndrome
下载PDF
导出
摘要 目的探讨不同冠脉病变支数的急性冠脉综合征患者血浆MMP-9水平。方法选取64例急性冠脉综合征患者,根据冠脉造影结果分为单支病变组、双支病变组、三支病变组,采用ELISA法测定各组研究对象的血浆MMP-9水平。结果单支病变组、双支病变组、三支病变组的MMP-9水平分别是(192.2±13.2)ng/mL、(236.6±14.5)ng/mL、(296.7±13.6)ng/mL,两两之间比较差异均有统计学意义(P<0.05)。结论急性冠脉综合征患者病变支数越多,血浆MMP-9水平越高,这提示血浆MMP-9水平可用于预测冠状动脉粥样硬化病变的严重程度。 Objective To explore plasma MMP-9 level of the different number of coronary lesions in patients with acute coronary syndrome. Methods According to coronary angiography,64 cases with acute coronary syndrome were divided into single-vessel disease groups,double vessel disease group and three lesions.To study the MMP-9 level measured by ELISA. Results The MMP-9 levels of single-vessel disease groups,double vessel disease group and three lesions respectively were (192.2 ±13.2)ng/mL,(236.6± 14.5)ng/mL and (296.7 ±13.6)ng/mL.There were significant differences between any two groups(P 〈 0.05). Conclusion The bigger number of diseased vessels in patients with acute coronary syndrome,the higher MMP-9 level in plasma.The MMP-9 level can be used to predict the severity of coronary atherosclerotic lesions.
作者 段军仓 王忠
出处 《中国医药科学》 2012年第13期39-40,共2页 China Medicine And Pharmacy
关键词 冠脉病变支数 急性冠脉综合征 MMP-9 Coronary lesions Acute coronary syndrome MMP-9
  • 相关文献

参考文献5

  • 1Giansante C, Fiotti N, Di Chiara A, et al.In-hosital outcome of patients with acute coronary syndrome:relationship with inflammation and remodeling markers[J].Caldiova Med, 2007,8 ( 8 ) : 602-607.
  • 2Suzuki M, Saito M, Nagai T, et al.Sygtemic venus coronary levels of intlammation in acute coronary syndroes[J].Angiology,2009,57 ( 4 ) : 459-463.
  • 3Jean-Pierre Bassand, Christian W Harem, Diego Ardissino, et al.Guide fnr the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes[J].HEJ,2007,28 ( 9 ) : 1598-1660.
  • 4李晓军,梁力建,吴宝安.普伐他汀对肝癌基质金属蛋白酶表达的影响[J].广西医学,2009,31(2):166-168. 被引量:2
  • 5Higo S, Uematsu M, Yamagishi M, et al.Elevating of plama matrix metalloproteinase-9 in the culprit coronary artery in patients with acute myocardial infarction:clinical evidence from distal protection[J].Circ J, 2005,69 (2): 1180-1185.

二级参考文献9

  • 1张弘,韩喜春,王悦书,韩刚,姜伟栋.基质金属蛋白酶抑制剂-3基因转染抗人肝癌细胞系侵袭与转移的研究[J].中华普通外科杂志,2004,19(6):379-380. 被引量:4
  • 2吴宝安,梁力建,李绍强,李晓军,彭宝岗.Lovastatin对肝癌HepG2细胞作用后基因差异表达的初步研究[J].中国病理生理杂志,2006,22(4):781-785. 被引量:3
  • 3Maatta M, Soini Y, Lialla A, ct al. Differential expression of matrix metalloproteinases (MMP) -2, MMP-9, and membrane typel-MMP in hepatocellar and pancreatic adenocareinoma: implications for tumor progression and clinical prognosis[ J]. Clin Cancer Res,2000,6 (8) : 2 726 -2 734.
  • 4Aril S,Mise M ,Harada T,et al. Overexpression of matrix metalloproteinases gene in hepatocellar carcinoma with invisive potential [ J]. Hepatology, 1996,24 ( 11 ) : 316 - 322.
  • 5Mort JD, Werb Z. Regulation of matrix biology by matrix metalloproteinases [ J ]. Curr Opin Cell Biol,2004,16 (5) :558 - 564.
  • 6Jodele S, Chantrain CF, Blavier L, et al. The contribution of bone marrow-derived cells to the tumor vasculature in neuroblastoma is matrix metalloproteinase-9 dependent [ J ]. Cancer Res, 2005,65 ( 8 ) : 3 200 -3 208.
  • 7Polette M, Nawrocki Raby B, Gilles C, et al. Tumor invasion and matrix metalloproteinases[ J ]. Crit Hey Oncol Hematol, 2004,49 ( 3 ) : 179 - 186.
  • 8Giannelli R, Bergamihi C, Fransvea E, et al. Human hepatocellar carcinoma (HCC) cells require both alpha 3 betal integrin and metalloproteinases activity for migration and invasion [ J ]. Lab Invest, 2001,81 (5) :613 - 627.
  • 9郑青平,陈龙华,石玉生,倪秉强.肝癌组织VEGF、HIF-1α和MMP-2表达的临床研究[J].广西医学,2008,30(3):308-311. 被引量:8

共引文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部